We have located links that may give you full text access.
Journal Article
Review
Thromboembolic disease and breathlessness.
Current Opinion in Supportive and Palliative Care 2016 September
PURPOSE OF REVIEW: Venous thromboembolism (VTE) comprising deep vein thrombosis and pulmonary embolus, confers a significant symptom burden in the supportive care setting, and yet is often unrecognized. Its management remains challenging because the clinical trials informing practice recruited patients that are largely unrepresentative of the advanced disease populations.
RECENT FINDINGS: Recent years have seen several developments in the management of VTE including new oral anticoagulants, an appreciation of the patient's experience of VTE, and the importance of considering other comorbidities in ensuring an individualized approach to VTE treatment.
SUMMARY: This study reviews the challenges of VTE management within supportive and palliative care, the new oral anticoagulants and the management of VTE in cases in which the evidence is lacking.
RECENT FINDINGS: Recent years have seen several developments in the management of VTE including new oral anticoagulants, an appreciation of the patient's experience of VTE, and the importance of considering other comorbidities in ensuring an individualized approach to VTE treatment.
SUMMARY: This study reviews the challenges of VTE management within supportive and palliative care, the new oral anticoagulants and the management of VTE in cases in which the evidence is lacking.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app